| First Author | Greilach SA | Year | 2023 |
| Journal | J Immunol | Volume | 210 |
| Issue | 11 | Pages | 1677-1686 |
| PubMed ID | 37083696 | Mgi Jnum | J:341064 |
| Mgi Id | MGI:7518426 | Doi | 10.4049/jimmunol.2200798 |
| Citation | Greilach SA, et al. (2023) Presentation of Human Neural Stem Cell Antigens Drives Regulatory T Cell Induction. J Immunol 210(11):1677-1686 |
| abstractText | Transplantation of human neural stem cells (hNSCs) is a promising regenerative therapy to promote remyelination in patients with multiple sclerosis (MS). Transplantation of hNSCs has been shown to increase the number of CD4+CD25+Foxp3+ T regulatory cells (Tregs) in the spinal cords of murine models of MS, which is correlated with a strong localized remyelination response. However, the mechanisms by which hNSC transplantation leads to an increase in Tregs in the CNS remains unclear. We report that hNSCs drive the conversion of T conventional (Tconv) cells into Tregs in vitro. Conversion of Tconv cells is Ag driven and fails to occur in the absence of TCR stimulation by cognate antigenic self-peptides. Furthermore, CNS Ags are sufficient to drive this conversion in the absence of hNSCs in vitro and in vivo. Importantly, only Ags presented in the thymus during T cell selection drive this Treg response. In this study, we investigate the mechanisms by which hNSC Ags drive the conversion of Tconv cells into Tregs and may provide key insight needed for the development of MS therapies. |
